ZA961412B - A method for the isolation and purification of lipid cell-wall components - Google Patents

A method for the isolation and purification of lipid cell-wall components

Info

Publication number
ZA961412B
ZA961412B ZA961412A ZA961412A ZA961412B ZA 961412 B ZA961412 B ZA 961412B ZA 961412 A ZA961412 A ZA 961412A ZA 961412 A ZA961412 A ZA 961412A ZA 961412 B ZA961412 B ZA 961412B
Authority
ZA
South Africa
Prior art keywords
derivatives
salts
mycolic acids
isolation
purification
Prior art date
Application number
ZA961412A
Other languages
English (en)
Inventor
Jan Adrianus Verschoor
Original Assignee
Adcock Ingram Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adcock Ingram Ltd filed Critical Adcock Ingram Ltd
Publication of ZA961412B publication Critical patent/ZA961412B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6463—Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/649—Biodiesel, i.e. fatty acid alkyl esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
ZA961412A 1995-02-22 1996-02-22 A method for the isolation and purification of lipid cell-wall components ZA961412B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA951464 1995-02-22

Publications (1)

Publication Number Publication Date
ZA961412B true ZA961412B (en) 1996-08-26

Family

ID=25584852

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961412A ZA961412B (en) 1995-02-22 1996-02-22 A method for the isolation and purification of lipid cell-wall components

Country Status (12)

Country Link
US (1) US6171830B1 (de)
EP (1) EP0811075B1 (de)
JP (1) JPH11500906A (de)
CN (1) CN1183811A (de)
AT (1) ATE395428T1 (de)
AU (1) AU720288B2 (de)
CA (1) CA2213428A1 (de)
DE (1) DE69637522D1 (de)
HU (1) HUP9900378A3 (de)
RU (1) RU2155230C2 (de)
WO (1) WO1996026288A1 (de)
ZA (1) ZA961412B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO359396A0 (en) 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
AU726734B2 (en) * 1996-11-13 2000-11-16 Centenary Institute Of Cancer Medicine & Cell Biology Mycobacterium cell wall compositions
CN1057077C (zh) * 1998-05-12 2000-10-04 中国医学科学院医药生物技术研究所 一种具有免疫抑制作用的化合物
CA3211104A1 (en) 2010-02-23 2011-09-01 University Of Washington Artificial mycolic acid membranes
PL2661253T3 (pl) 2011-01-04 2017-08-31 Archivel Farma, Sl Preparat liposomowy odpowiedni do leczenia lub zapobiegania gruźlicy
CN104411326B (zh) 2012-01-12 2018-02-02 阿尔西维尔法尔玛公司 抗哮喘的mtb‑c疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877612A (en) * 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
US5006514A (en) 1986-03-20 1991-04-09 Sawai Pharmaceutical Co., Ltd. α,α-trehalose trimycolates and pharmaceutical compositions
DK0751780T3 (da) 1993-06-21 2003-10-13 Brigham & Womens Hospital Fremgangsmåder til isolering af CD1-fremviste antigener, vacciner, som omfatter CD1-fremviste antigener, og cellelinier til anvendelse i nævnte fremgangsmåder
WO1995028642A1 (en) 1994-04-14 1995-10-26 Brown, Keith, Edwin, Frank A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein

Also Published As

Publication number Publication date
AU4728796A (en) 1996-09-11
HUP9900378A2 (hu) 1999-05-28
JPH11500906A (ja) 1999-01-26
ATE395428T1 (de) 2008-05-15
CA2213428A1 (en) 1996-08-29
CN1183811A (zh) 1998-06-03
DE69637522D1 (de) 2008-06-26
US6171830B1 (en) 2001-01-09
HUP9900378A3 (en) 1999-11-29
RU2155230C2 (ru) 2000-08-27
EP0811075A1 (de) 1997-12-10
EP0811075B1 (de) 2008-05-14
AU720288B2 (en) 2000-05-25
WO1996026288A1 (en) 1996-08-29

Similar Documents

Publication Publication Date Title
DE59608686D1 (de) Verfahren zur Entfernung von unerwünschten lipophilen Verunreinigungen und/oder Rückständen, welche in Getränken oder pflanzlichen Zubereitungen enthalten sind
FI945186A (fi) Uusi uuttomenetelmä luonnossa esiintyvien makrolidien talteenottamiseksi
MY141766A (en) Extraction process for removal of impurities from an aqueous mixture
WO2000078741A3 (en) Process for extraction and purification of paclitaxel from natural sources
ATE203057T1 (de) Verfahren zur industriellen herstellung von phosphatidylserine
SE8402861D0 (sv) Rening av biologiskt material
ZA961412B (en) A method for the isolation and purification of lipid cell-wall components
WO1994008708A3 (en) Compositions of fatty acid esters of hexitans
ATE147066T1 (de) Verfahren zum abtrennen von aminosäuren aus wässrigen lösungen
FR2670771B1 (de)
DE3376000D1 (en) Process for the purification of wet-process phosphoric acid
GB2343786A (en) Order charge separation and order-charge type separation
BR9714138A (pt) Processo para a cristalização por suspensão.
EP0282003A3 (en) Method for removing organic materials dissolved in purified phosphoric acid
DE68928249D1 (de) Verfahren zur Trennung von Methylester von alpha-L-aspartyl-L-phenylalaninen
DE3763068D1 (de) Verfahren zur abtrennung und reinigung organischer substanzen von begleitstoffen.
Leybros Process for extracting and concentrating cadmium in low and intermediate concentrations in concentrated sulphuric effluents
HK1005027A1 (en) Process for purification of 1,2-bis(nicotinamido) propane
JPS5612339A (en) Purification of trimethoxybenzoic acid
TH933A (th) กรรมวิธีของการผลิตสตีวิโอไซต์บริสุทธิ์